ID MCRX_METTM Reviewed; 553 AA. AC P58815; D9PXZ3; DT 10-MAY-2002, integrated into UniProtKB/Swiss-Prot. DT 30-NOV-2010, sequence version 2. DT 27-MAR-2024, entry version 85. DE RecName: Full=Methyl-coenzyme M reductase II subunit alpha {ECO:0000303|PubMed:2269306}; DE Short=MCR II alpha {ECO:0000303|PubMed:2269306}; DE EC=2.8.4.1 {ECO:0000269|PubMed:2269306}; GN Name=mrtA; OrderedLocusNames=MTBMA_c15120; OS Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM OS 14651 / NBRC 100331 / OCM 82 / Marburg) (Methanobacterium OS thermoautotrophicum). OC Archaea; Euryarchaeota; Methanomada group; Methanobacteria; OC Methanobacteriales; Methanobacteriaceae; Methanothermobacter. OX NCBI_TaxID=79929; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / RC Marburg; RX PubMed=20802048; DOI=10.1128/jb.00844-10; RA Liesegang H., Kaster A.K., Wiezer A., Goenrich M., Wollherr A., Seedorf H., RA Gottschalk G., Thauer R.K.; RT "Complete genome sequence of Methanothermobacter marburgensis, a RT methanoarchaeon model organism."; RL J. Bacteriol. 192:5850-5851(2010). RN [2] RP PROTEIN SEQUENCE OF 1-14, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL RP PROPERTIES, SUBUNIT, AND DEVELOPMENTAL STAGE. RC STRAIN=ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / RC Marburg; RX PubMed=2269306; DOI=10.1111/j.1432-1033.1990.tb19481.x; RA Rospert S., Linder D., Ellermann J., Thauer R.K.; RT "Two genetically distinct methyl-coenzyme M reductases in Methanobacterium RT thermoautotrophicum strain Marburg and delta H."; RL Eur. J. Biochem. 194:871-877(1990). RN [3] {ECO:0007744|PDB:5A8R} RP X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) IN COMPLEX WITH COENZYME F430; RP COENZYME B; COENZYME M AND MCR SUBUNITS BETA AND GAMMA, COFACTOR, RP METHYLATION AT HIS-260; ARG-274; GLN-402 AND CYS-454, THIOCARBOXYLATION AT RP GLY-447, DEHYDROGENATION AT ASP-452, AND SUBUNIT. RC STRAIN=ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / RC Marburg; RX PubMed=27467699; DOI=10.1002/anie.201603882; RA Wagner T., Kahnt J., Ermler U., Shima S.; RT "Didehydroaspartate Modification in Methyl-CoenzymeM Reductase Catalyzing RT Methane Formation."; RL Angew. Chem. Int. Ed. Engl. 55:10630-10633(2016). CC -!- FUNCTION: Component of the methyl-coenzyme M reductase (MCR) I that CC catalyzes the reductive cleavage of methyl-coenzyme M (CoM-S-CH3 or 2- CC (methylthio)ethanesulfonate) using coenzyme B (CoB or 7- CC mercaptoheptanoylthreonine phosphate) as reductant which results in the CC production of methane and the mixed heterodisulfide of CoB and CoM CC (CoM-S-S-CoB). This is the final step in methanogenesis. CC {ECO:0000269|PubMed:2269306}. CC -!- CATALYTIC ACTIVITY: CC Reaction=coenzyme B + methyl-coenzyme M = coenzyme M-coenzyme B CC heterodisulfide + methane; Xref=Rhea:RHEA:12532, ChEBI:CHEBI:16183, CC ChEBI:CHEBI:58286, ChEBI:CHEBI:58411, ChEBI:CHEBI:58596; EC=2.8.4.1; CC Evidence={ECO:0000269|PubMed:2269306}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12533; CC Evidence={ECO:0000305|PubMed:2269306}; CC -!- COFACTOR: CC Name=coenzyme F430; Xref=ChEBI:CHEBI:60540; CC Evidence={ECO:0000269|PubMed:27467699}; CC Note=Binds 2 coenzyme F430 non-covalently per MCR complex. Coenzyme CC F430 is a yellow nickel porphinoid (PubMed:27467699). Methyl-coenzyme-M CC reductase is activated when the enzyme-bound coenzyme F430 is reduced CC to the Ni(I) oxidation state (By similarity). CC {ECO:0000250|UniProtKB:P11558, ECO:0000269|PubMed:27467699}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=75 uM for coenzyme B {ECO:0000269|PubMed:2269306}; CC KM=4 mM for methyl-coenzyme M {ECO:0000269|PubMed:2269306}; CC -!- PATHWAY: One-carbon metabolism; methyl-coenzyme M reduction; methane CC from methyl-coenzyme M: step 1/1. {ECO:0000305|PubMed:2269306}. CC -!- SUBUNIT: MCR is a hexamer of two alpha, two beta, and two gamma chains, CC forming a dimer of heterotrimers. {ECO:0000269|PubMed:2269306}. CC -!- DEVELOPMENTAL STAGE: There are two MCR complexes in this bacteria. MCR CC II is expressed in the early growth phase. Late growth cells contain CC mostly MCR I. {ECO:0000269|PubMed:2269306, CC ECO:0000269|PubMed:27467699}. CC -!- PTM: The alpha subunit contains six modified amino acids near the CC active site region. Is methylated on His-260, Arg-274, Gln-402 and Cys- CC 454, probably by the action of specific S-adenosylmethionine-dependent CC methyltransferases. Also contains a thioglycine at position 447, CC forming a thiopeptide bond. Contains a didehydroaspartate residue at CC position 452 (PubMed:27467699). The methylation on C5 of Arg-274 is a CC post-translational methylation not essential in vivo, but which plays a CC role for the stability and structural integrity of MCR (By similarity). CC {ECO:0000250|UniProtKB:Q8THH1, ECO:0000269|PubMed:27467699}. CC -!- SIMILARITY: Belongs to the methyl-coenzyme M reductase alpha subunit CC family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CP001710; ADL59091.1; -; Genomic_DNA. DR RefSeq; WP_013296302.1; NC_014408.1. DR PDB; 5A8R; X-ray; 2.15 A; A/D/G/J=1-553. DR PDBsum; 5A8R; -. DR AlphaFoldDB; P58815; -. DR SMR; P58815; -. DR STRING; 79929.MTBMA_c15120; -. DR iPTMnet; P58815; -. DR PaxDb; 79929-MTBMA_c15120; -. DR GeneID; 9705221; -. DR KEGG; mmg:MTBMA_c15120; -. DR PATRIC; fig|79929.8.peg.1465; -. DR HOGENOM; CLU_493170_0_0_2; -. DR OrthoDB; 52468at2157; -. DR UniPathway; UPA00646; UER00699. DR Proteomes; UP000000345; Chromosome. DR GO; GO:0050524; F:coenzyme-B sulfoethylthiotransferase activity; IEA:UniProtKB-EC. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0015948; P:methanogenesis; IEA:UniProtKB-KW. DR Gene3D; 3.30.70.470; -; 1. DR Gene3D; 1.20.840.10; Methyl-coenzyme M reductase, alpha/beta subunit, C-terminal; 1. DR InterPro; IPR016212; Me_CoM_Rdtase_asu. DR InterPro; IPR008924; Me_CoM_Rdtase_asu/bsu_C. DR InterPro; IPR009047; Me_CoM_Rdtase_asu_C. DR InterPro; IPR003183; Me_CoM_Rdtase_asu_N. DR InterPro; IPR015811; Me_CoM_Rdtase_asu_N_sub1. DR InterPro; IPR015823; Me_CoM_Rdtase_asu_N_sub2. DR InterPro; IPR009024; Me_CoM_Rdtase_Fd-like_fold. DR NCBIfam; TIGR03256; met_CoM_red_alp; 1. DR Pfam; PF02249; MCR_alpha; 1. DR Pfam; PF02745; MCR_alpha_N; 1. DR PIRSF; PIRSF000262; MCR_alpha; 1. DR SUPFAM; SSF48081; Methyl-coenzyme M reductase alpha and beta chain C-terminal domain; 1. DR SUPFAM; SSF55088; Methyl-coenzyme M reductase subunits; 1. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Metal-binding; Methanogenesis; KW Methylation; Nickel; Transferase. FT CHAIN 1..553 FT /note="Methyl-coenzyme M reductase II subunit alpha" FT /id="PRO_0000147458" FT BINDING 150 FT /ligand="coenzyme F430" FT /ligand_id="ChEBI:CHEBI:60540" FT /ligand_part="Ni" FT /ligand_part_id="ChEBI:CHEBI:28112" FT /note="axial binding residue" FT /evidence="ECO:0000269|PubMed:27467699, FT ECO:0007744|PDB:5A8R" FT BINDING 228 FT /ligand="coenzyme B" FT /ligand_id="ChEBI:CHEBI:58596" FT /ligand_note="ligand shared between two alpha subunits" FT /note="in chain A" FT /evidence="ECO:0000269|PubMed:27467699, FT ECO:0007744|PDB:5A8R" FT BINDING 259..260 FT /ligand="coenzyme B" FT /ligand_id="ChEBI:CHEBI:58596" FT /ligand_note="ligand shared between two alpha subunits" FT /note="in chain A" FT /evidence="ECO:0000269|PubMed:27467699, FT ECO:0007744|PDB:5A8R" FT BINDING 273 FT /ligand="coenzyme B" FT /ligand_id="ChEBI:CHEBI:58596" FT /ligand_note="ligand shared between two alpha subunits" FT /note="in chain B" FT /evidence="ECO:0000269|PubMed:27467699, FT ECO:0007744|PDB:5A8R" FT BINDING 335 FT /ligand="coenzyme M" FT /ligand_id="ChEBI:CHEBI:58319" FT /evidence="ECO:0000269|PubMed:27467699, FT ECO:0007744|PDB:5A8R" FT BINDING 446 FT /ligand="coenzyme M" FT /ligand_id="ChEBI:CHEBI:58319" FT /evidence="ECO:0000269|PubMed:27467699, FT ECO:0007744|PDB:5A8R" FT MOD_RES 260 FT /note="Pros-methylhistidine" FT /evidence="ECO:0000269|PubMed:27467699" FT MOD_RES 274 FT /note="5-methylarginine" FT /evidence="ECO:0000269|PubMed:27467699" FT MOD_RES 402 FT /note="2-methylglutamine" FT /evidence="ECO:0000269|PubMed:27467699" FT MOD_RES 447 FT /note="1-thioglycine" FT /evidence="ECO:0000269|PubMed:27467699" FT MOD_RES 452 FT /note="(Z)-2,3-didehydroaspartate" FT /evidence="ECO:0000269|PubMed:27467699" FT MOD_RES 454 FT /note="S-methylcysteine" FT /evidence="ECO:0000269|PubMed:27467699" FT CONFLICT 2 FT /note="D -> L (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" FT HELIX 8..14 FT /evidence="ECO:0007829|PDB:5A8R" FT TURN 15..17 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 32..35 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 37..48 FT /evidence="ECO:0007829|PDB:5A8R" FT TURN 49..55 FT /evidence="ECO:0007829|PDB:5A8R" FT STRAND 63..65 FT /evidence="ECO:0007829|PDB:5A8R" FT STRAND 74..77 FT /evidence="ECO:0007829|PDB:5A8R" FT STRAND 83..85 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 86..89 FT /evidence="ECO:0007829|PDB:5A8R" FT TURN 91..93 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 95..105 FT /evidence="ECO:0007829|PDB:5A8R" FT STRAND 107..112 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 113..121 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 129..142 FT /evidence="ECO:0007829|PDB:5A8R" FT TURN 143..145 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 158..160 FT /evidence="ECO:0007829|PDB:5A8R" FT STRAND 165..171 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 173..178 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 181..183 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 187..190 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 193..203 FT /evidence="ECO:0007829|PDB:5A8R" FT STRAND 207..212 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 215..220 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 225..241 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 251..259 FT /evidence="ECO:0007829|PDB:5A8R" FT TURN 260..262 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 272..274 FT /evidence="ECO:0007829|PDB:5A8R" FT STRAND 278..280 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 281..283 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 286..292 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 295..297 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 302..317 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 318..325 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 333..337 FT /evidence="ECO:0007829|PDB:5A8R" FT TURN 338..340 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 344..359 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 369..389 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 391..396 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 400..419 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 422..440 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 455..459 FT /evidence="ECO:0007829|PDB:5A8R" FT TURN 464..466 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 470..472 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 478..480 FT /evidence="ECO:0007829|PDB:5A8R" FT STRAND 484..486 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 487..501 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 509..514 FT /evidence="ECO:0007829|PDB:5A8R" FT STRAND 520..522 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 527..535 FT /evidence="ECO:0007829|PDB:5A8R" FT HELIX 546..548 FT /evidence="ECO:0007829|PDB:5A8R" SQ SEQUENCE 553 AA; 60678 MW; 94CC0D641E7C8271 CRC64; MDEKKLFLKA LKKKFEGEDP DEKYTNFYCF GGWEQSARKK EFTEYAKKAA EKRGGIPFYN PDIGVPLGQR KLMAYRVSGT DAYVEGDDLH FVNNAAIQQM VDDIKRTVIV GMDTAHAVLE KRLGVEVTPE TINEYMEAIN HALPGGAVVQ EHMVEVHPGL VEDCYAKIFT GDDNLADELD KRILIDINKE FPEEQAEQLK SYIGNRTYQV NRVPTIVVRT CDGGTVSRWS AMQIGMSFIS AYKLCAGEAA IADFSYAAKH ADVIEMGTIM PARRARGPNE PGGVAFGTFA DIVQTSRVSD DPANVSLEVI AGAAALYDQV WLGSYMSGGV GFTQYATAAY TDDILDDFVY YGMEYVDDKY GICGTKPTMD VVRDISTEVT LYSLEQYEEY PTLLEDHFGG SQRAAVAAAA AGCSTAFATG NSNAGINGWY LSQILHKEAH SRLGFYGYDL QDQCGASNSL SIRSDEGLIH ELRGPNYPNY AMNVGHQPEY AGIAQAPHAA RGDAFCTNPL IKVAFADKDL AFDFTSPRKS IAAGALREFM PEGERDLIIP AGK //